ZTS · NYSE · CIK 0001555280

Zoetis Inc.

Zoetis Inc.’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 13, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $9.5B and net income of $2.7B, according to its XBRL data on EDGAR. Its EDGAR record lists 108 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$9.5B
Net income, FY2025
$2.7B
Form 4 filings on record, past 12 months
108

Company overview

Legal name (as filed)
Zoetis Inc.
Ticker
ZTS
SEC Central Index Key (CIK)
0001555280
Industry (SIC)
Pharmaceutical Preparations (code 2834)
Business address
PARSIPPANY, NJ
State or country of incorporation
—
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#429 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Zoetis Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$7.8BFY2021$8.1BFY2022$8.5BFY2023$9.3BFY2024$9.5BFY2025
Net income
$2.0BFY2021$2.1BFY2022$2.3BFY2023$2.5BFY2024$2.7BFY2025
ZTS annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$7.8B$8.1B$8.5B$9.3B$9.5B
Net income$2.0B$2.1B$2.3B$2.5B$2.7B
Diluted EPS$4.27$4.49$5.07$5.47$6.02
Total assets$13.9B$14.9B$14.3B$14.2B$15.5B
Cash and equivalents$3.5B$3.6B$2.0B$2.0B$2.3B

XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

ZTS latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Feb 12, 202610-KAnnual report· period Dec 31, 2025Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Oct 13, 20268-KDirector or officer change; Regulation FD disclosure· period Oct 8, 2026Document · Index
Apr 8, 2026DEF 14ADefinitive proxy statement· period Dec 31, 2025Document · Index

Recent SEC filings

The 40 newest documents filed by or about Zoetis Inc., by form type:

4 ×278-K ×63 ×210-Q ×1SCHEDULE 13G/A ×13/A ×111-K ×1SD ×1
ZTS recent filings
FiledFormWhat it isOriginal
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20268-KDirector or officer change; Regulation FD disclosure· period Oct 8, 2026Document · Index
Oct 8, 20268-KRegulation FD disclosure· period Oct 8, 2026Document · Index
Oct 2, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026Document · Index
Sep 18, 20264Statement of changes in beneficial ownership (insider trade)· period Sep 17, 2026Document · Index
Sep 2, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 31, 2026Document · Index
Aug 24, 20263Initial statement of beneficial ownership· period Aug 17, 2026Document · Index
Aug 11, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 7, 2026Document · Index
Aug 6, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 6, 20268-KResults of operations· period Aug 6, 2026Document · Index
Aug 6, 20268-KDirector or officer change· period Aug 6, 2026Document · Index
Jul 30, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jul 14, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 10, 2026Document · Index
Jul 14, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 10, 2026Document · Index
Jul 14, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 10, 2026Document · Index
Jul 14, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 10, 2026Document · Index
Jul 14, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 10, 2026Document · Index
Jul 14, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 10, 2026Document · Index
Jul 14, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 10, 2026Document · Index
Jul 14, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 10, 2026Document · Index
Jul 14, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 10, 2026Document · Index
Jul 14, 20263/AInitial statement of beneficial ownership· period Jun 15, 2026Document · Index
Jun 22, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 18, 2026Document · Index
Jun 22, 202611-KAnnual report of employee stock plans· period Dec 31, 2025Document · Index
Jun 17, 20263Initial statement of beneficial ownership· period Jun 15, 2026Document · Index
Jun 11, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 10, 2026Document · Index
May 28, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 26, 20264Statement of changes in beneficial ownership (insider trade)· period May 21, 2026Document · Index
May 22, 20268-KDirector or officer change; Shareholder vote results· period May 20, 2026Document · Index
May 21, 20264Statement of changes in beneficial ownership (insider trade)· period May 20, 2026Document · Index
May 20, 20268-KRegulation FD disclosure· period May 20, 2026Document · Index
May 13, 20264Statement of changes in beneficial ownership (insider trade)· period May 13, 2026Document · Index
May 13, 20264Statement of changes in beneficial ownership (insider trade)· period May 13, 2026Document · Index

Insider filing activity

108 Form 4 filings appear in Zoetis Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Pharmaceutical Preparations

All 194 companies in Pharmaceutical Preparations· Companies headquartered in New Jersey

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001555280 and XBRL company facts. Zoetis Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.